Upharmacia July 2017
HEALTHCARE NEWS
V oting for M edical R eform
U ndermined
On Jul 8, Ukrainian Parliament
preliminarily approved the Draft
Law #6327 on state financial
guaranties in provision of medical
services and drugs. Afterwards, the
document was proceeded by the
Parliamentary Committee on Public
Health.The MPs proposed 886 edits
to the Draft Law; 396 of them were
approved in the end. However,
according to the acting Head of the
MOH Ulana Suprun, the Head of
the Parliamentary Committee Olga
Bogomolets refused to sign the
document for voting. Consequently,
the document was signed by the
Deputy Head of the Committee, but
the Parliament didn’t have time to
vote the Draft Law.
Therefore, the approval of the
medical reform actively pushed
by the MOH, was sabotaged in
the Parliament. According to
the board member of the Anti
Corruption Action Centre, the
blocking of the medical reform is
in the interests of the medical elite,
which uncontrolledly manages the
budgets of medical institutions.
The voting for the reform was
postponed till Sep, when the
Parliament resumes its work. Ms.
Suprun stated that the MOH would
continue working on the reform
implementation.
Among 199 drugs, 21 are produced
in the EU, 17 – in Ukraine, 4 – in
India, 1 – Israel.
The reimbursement program
“Affordable drugs” was launched in
April 2017. Since then, the 3.6 mio
prescriptions were issued and fully
or partially payed by the state. As on
middle Jul, about 6.2k pharmacies in
Ukraine participate in the program.
T he MOH I nitiated C reation of
P rocurement A gency
The MOH submitted to the
government the Draft Resolution
on creation of the National
Procurement agency, which is to
carry out procurement of drugs
and medical devices. Accordion to
the acting Minister, the agency is
supposed to be launched in 2019.
At the same time, the MOH signed
agreements with international
organizations (UNDR, Crown
Agents and UNICEF) on delegated
procurement of drugs and medical
devices for the state budget funds
of 2017. The organizations have
already supplied 98% of medical
products procured for the funds of
2016.
N ew R eimbursement L ist
A pproved
The MOH approved the new
register of drugs, which are subject
to reimbursement. The list was
expanded by 33 new position to 199
names. The value of 30 drugs will
be reimbursed 100% by state, the
other positions assume co-payment.
www.upharma-c.com
9